Study: MicroRNA cooperation mutes breast cancer oncogenes

Enhancing a few microRNAs may offer as much anti-breast-cancer activity as enhancing one, many times over -- and without the side effects

2013-05-07

(Press-News.org) A University of Colorado Cancer Center study recently published in the journal Cell Death & Disease shows that turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot – and without the unwanted side effects.

It's a bit like the classic thought experiment known as the "tumor problem" formulated by Karl Dunker in 1945 and used frequently in the problem-solving literature: Imagine a person suffers from a malignant tumor in the center of her body. Radiation strong enough to kill the tumor kills any healthy tissue through which it passes. Without operating or killing healthy tissue, how can a doctor use radiation to kill the tumor?

The answer is to target the tumor from many angles – many weak rays of radiation pass harmlessly through healthy tissue, but their combined power at the point of the tumor is enough to kill it.

In the present study, CU Cancer Center investigators used "weak" induction of multiple microRNAs that combined from many angles to regulate the known breast cancer oncogenes erbB2/erbB3 (the "tumor") without regulating non-target genes (the "healthy tissue").

"Imagine you have a microRNA that regulates genes A and B. Then you have another microRNA that regulates genes B and C. You amplify each microRNA to a degree that doesn't effect gene A or C, but their combined effect regulates gene B," says Bolin Liu, MD, assistant professor in the Department of Pathology at the University of Colorado School of Medicine.

microRNA is an attractive target in cancer therapy – more microRNA can lead to less gene expression, turning down or off the oncogenes that cause cancer. However, to get the desired effect on gene expression frequently requires enhancing microRNA expression 100- or 1,000-fold (or more). And the induced microRNA likely has other genetic targets – it will turn down other genes as well as the oncogene, sometimes with unfortunate consequences.

"The current study showed that two microRNAs enhanced only 3-to-6 times their natural expression could cooperate to regulate an oncogene that had previously only been affected by a microRNA enhanced by many, many times this amount," Liu says.

Specifically, the group's work shows that no one alone, but any two of the three microRNAs that regulate erbB2/erbB3 expression can affect the levels of proteins produced by the genes. These are miR-125a, miR-15b, and miR-205, which act in concert to regulate the expression of erbB2/erbB3, which are cancer-causing products of the oncogenes.

But in general, the group's novel technique could have implications far past erbB2/erbB3, allowing researchers and eventually doctors to mute the genes they want to mute without also dampening the expression of genes regulated by only one or only the other microRNA partner.

### END

ELSE PRESS RELEASES FROM THIS DATE:

ER visits for urinary tract infections add almost $4 billion a year in unnecessary costs

2013-05-07

SAN DIEGO – Giving patients better access to primary health care could save nearly $4 billion a year in unnecessary emergency room visits for a single common complaint – urinary tract infections – according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit. The study set out to determine the economic burden of 10.8 million patients, with a primary diagnosis of urinary tract infection, who went to U.S. emergency rooms for treatment from the beginning of 2006 to the end of 2009. The findings will be presented May 6 at the annual meeting of ...

Annals of Internal Medicine tip sheet for May 7, 2013

2013-05-07

1. Ambrisentan Not Appropriate for Patients with Idiopathic Pulmonary Fibrosis Ambrisentan should not be used to treat patients for idiopathic pulmonary fibrosis (IPF). IPF is a fatal form of chronic, progressive lung disease characterized by irreversible scarring around both lungs. IPF causes about 5,000 deaths each year and currently there is no approved treatment. Researchers do not know what causes IPF, but a protein called endothelin-1 that causes the blood vessels to contract and induces lung scarring and proliferation has been associated with the disease. Researchers ...

MS may not be as rare as thought in African-Americans

2013-05-07

MINNEAPOLIS – Contrary to a widely accepted belief, African-Americans may have a higher rather than lower risk of developing multiple sclerosis (MS) than Caucasians, according to a new study in the May 7, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology. "Our population-based study is the first of its kind to look at this question. The belief (that African- Americans have a lower risk of developing MS) was based on evidence that was problematic," said study author Annette Langer-Gould, MD, with Kaiser Permanente Southern California ...

Helping kids with severe respiratory failure survive until lung transplantation

2013-05-07

Minneapolis, MN, May 6, 2013 – Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been "bridged" toward lung transplantation with novel lung assist devices such as the Novalung. This and related devices work based on pumpless application of oxygenators. A presentation by David M. Hoganson, MD, and colleagues from Washington University School of Medicine in St. Louis at the Congenital Heart Disease Session of the 93rd AATS Annual Meeting describes the first time application of this technology to ...

Study finds black women have higher incidence of multiple sclerosis than white women

2013-05-07

PASADENA, Calif., May 6, 2013 – Multiple sclerosis is more common in black women than in white women, according to a Kaiser Permanente study published today in the journal Neurology. The findings run contrary to the widely accepted belief that blacks are less susceptible to MS, according to the researchers. Researchers examined the electronic health records of more than 3.5 million members of Kaiser Permanente Southern California between January 2008 and December 2011 and identified 496 people newly diagnosed with MS. Of these diagnosed cases, black patients had a 47 ...

Medical innovation/quality improvement platform featured in Health Affairs

2013-05-07

Boston, Mass. –A quality improvement platform developed at Boston Children's Hospital could help health care provider groups continuously improve their medical practice, curbing costs and improving patient outcomes. Successful outcomes associated with the platform, called Standardized Clinical Assessment and Management Plans (SCAMPs) and supported by a consortium of Massachusetts payers, are featured in the May issue of Health Affairs. SCAMPs start with existing practice recommendations, but are continuously revised as clinicians learn from everyday patient encounters. ...

Effects of stress on brain cells offer clues to new anti-depressant drugs

2013-05-07

Research from King's College London reveals the detailed mechanism behind how stress hormones reduce the number of new brain cells - a process considered to be linked to depression. The researchers identified a key protein responsible for the long-term detrimental effect of stress on cells, and importantly, successfully used a drug compound to block this effect, offering a potential new avenue for drug discovery. The study, published in Proceedings of the National Academy of Sciences (PNAS) was co-funded by the National Institute for Health Research Biomedical Research ...

New antiviral treatment could significantly reduce global burden of hepatitis C

2013-05-07

Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. 1 New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could potentially reduce HCV rates in some cities affected by chronic HCV prevalence by half over 15 years. In Europe, the US and other developed countries the majority of HCV infections ...

Major international TEDDY study finds no link between viral infection and rapidly developing Type 1 diabetes in young children

2013-05-07

Some of the earliest results from The Environmental Determinants of Diabetes in The Young (TEDDY) study - a major Europe-USA consortium exploring the causes of type 1 diabetes in children – has found no evidence for viral infection as a cause of the rapid-onset form of the condition. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD) and is by Professor Anette-Gabriele Ziegler of the German Research Centre for Environmental Health (Helmholtz Zentrum München), Munich, Germany, and colleagues across the USA and Europe, ...

Bats use blood to reshape tongue for feeding

2013-05-07

VIDEO: Cally Harper of Brown University explains how the bats she studied have evolved to lap up extra nectar using blood-filled "hairs " on their tongues. She also discusses how they could... Click here for more information. PROVIDENCE, R.I. [Brown University] — Nectar-feeding bats and busy janitors have at least two things in common: They want to wipe up as much liquid as they can as fast as they can, and they have specific equipment for the job. A study in the ...